Tag: Society of Nuclear Medicine and Molecular Imaging

Gallium 68 PET/CT Scanning for Neuroendocrine Tumors — Information and Locations

April 6, 2017

The US Food and Drug Administration’s (FDA) June 1, 2016 approval of the Gallium-68 PET/CT DOTATATE scan using NETSPOT® heralded a new age of nuclear imaging for neuroendocrine tumors in the United States.

PLEASE SCROLL DOWN FOR A STATE-BY STATE LISTREAD MORE

One Step Closer in the US to Peptide Receptor Radionuclide Therapy, PRRT, for Neuroendocrine Cancers

May 3, 2016

The clock is ticking!! With Advanced Accelerator Applications’ completed New Drug Application (NDA) submission of Lutathera to the U.S. Food and Drug Administration last week, a decision from the FDA is expected by early 2017.  Additionally, an

READ MORE
3rd Theranostics World Congress, The Clinician's Perspective, Thomas O'Dorisio, MD

15 Videos from the 3rd Theranostics World Congress

May 14, 2015

The 3rd Theranostics World Congress featured a patient education day on Saturday, March 14, made possible with support from the Carcinoid Cancer Foundation and the Caring for Carcinoid Foundation. The NorCal CarciNET Community provided funding to…

READ MORE
3rd Theranostics World Congress

3rd Theranostics World Congress Offers Free Patient Program on March 14

February 27, 2015

Johns Hopkins University in Baltimore, Maryland will be the site of the 3rd Theranostics World Congress on Ga-68 & PRRT from March 12-14, 2015. Co-sponsored by the Society of Nuclear Medicine and Molecular Imaging and Johns Hopkins Medicine, the…

READ MORE
Josh Mailman

Josh Mailman’s Patient Perspective on Integrative Oncology

November 20, 2014

“A Patient’s Perspective on Integrative Oncology:  Getting Past the ‘War,’ Living with and Beyond Cancer” by Josh Mailman has been published in the November 2014 issue of the Journal of the National Cancer Institute Monographs focused …

READ MORE
Josh Mailman, Chair, Patient Advocacy Advisory Board, Society of Nuclear Medicine and Molecular Imaging

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging 2014 Meeting

April 25, 2014

Josh Mailman, President of the NorCal CarciNET Community  and Chair of the Patient Advocacy Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day on June…

READ MORE
Jim Weiveris Winner of the 2013 Warner Advocacy Award

10 Highlights of the Year 2013 for the Carcinoid and Neuroendocrine Tumor Community

December 18, 2013

As the Carcinoid Cancer Foundation looks back on the year 2013, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…

READ MORE
Society of Nuclear Medicine and Molecular Imaging, Patient Program, June 9, 2013, Vancouver, Canada

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program

May 22, 2013

Josh Mailman, President of the NorCal CarciNET support group and Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day …

READ MORE